Seeing Is Believing

Currently out of the existing stock ratings of Karl Keirstead, 278 are a BUY (42.77%), 361 are a HOLD (55.54%), 11 are a SELL (1.69%).
Analyst Karl Keirstead, currently employed at UBS, carries an average stock price target met ratio of 84.71% that have a potential upside of 20.29% achieved within 263 days.
Karl Keirstead’s has documented 1,307 price targets and ratings displayed on 44 stocks. The coverage is on Technology, Healthcare, Industrials, Communication Services sectors.
Most recent stock forecast was given on MDB, MongoDB.
Analyst best performing recommendations are on NTNX (NUTANIX).
The best stock recommendation documented was for ORCL (ORACLE) at 9/8/2025. The price target of $280 was fulfilled within 2 days with a profit of $44.21 (18.75%) receiving and performance score of 93.75.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Dec-2023
$290
$52.31 (22.01%)
$250
19 days ago
(14-Sep-2026)
4/24 (16.67%)
$24.4 (9.19%)
35
Hold Since 23-Feb-2022
$255
$17.31 (7.28%)
$225
22 days ago
(11-Sep-2026)
21/34 (61.76%)
$2.77 (1.10%)
79
Buy Since 21-Mar-2022
$315
$77.31 (32.53%)
$315
22 days ago
(11-Sep-2026)
11/35 (31.43%)
$62.77 (24.89%)
202
Buy Since 16-Jun-2023
$270
$32.31 (13.59%)
$250
22 days ago
(11-Sep-2026)
10/28 (35.71%)
$17.77 (7.05%)
101
Hold Since 08-Jan-2026
$275
$37.31 (15.70%)
$285
22 days ago
(11-Sep-2026)
43/57 (75.44%)
$22.77 (9.03%)
176
Which stock is Karl Keirstead most bullish on?
Which stock is Karl Keirstead most reserved on?
What Year was the first public recommendation made by Karl Keirstead?